Your browser doesn't support javascript.
loading
First molecular approach to diagnose paediatric pulmonary lophomoniasis: A case series.
Taheri, Amirmasoud; Fakhar, Mahdi; Nakhaei, Maryam; Banimostafavi, Elham Sadat; Masiha, Farzad; Ghaffari, Javad; Sheydai, Soroush; Rezaei, Mohammad Sadegh; Sharifpour, Ali.
Afiliação
  • Taheri A; Toxoplasmosis Research Center, Communicable Diseases Institute Iranian National Registry Center for Lophomoniasis (INRCL), Mazandaran University of Medical Sciences Sari Iran.
  • Fakhar M; Toxoplasmosis Research Center, Communicable Diseases Institute Iranian National Registry Center for Lophomoniasis (INRCL), Mazandaran University of Medical Sciences Sari Iran.
  • Nakhaei M; Toxoplasmosis Research Center, Communicable Diseases Institute Iranian National Registry Center for Lophomoniasis (INRCL), Mazandaran University of Medical Sciences Sari Iran.
  • Banimostafavi ES; Toxoplasmosis Research Center, Communicable Diseases Institute Iranian National Registry Center for Lophomoniasis (INRCL), Mazandaran University of Medical Sciences Sari Iran.
  • Masiha F; Radiology Department Iranian National Registry Center for Lophomoniasis (INRCL), Mazandaran University of Medical Sciences Sari Iran.
  • Ghaffari J; Department of Pediatrics, Pediatric Infectious Diseases Research Center Communicable Diseases Institute, Mazandaran University of Medical Sciences Sari Iran.
  • Sheydai S; Department of Pediatrics, Pediatric Infectious Diseases Research Center Communicable Diseases Institute, Mazandaran University of Medical Sciences Sari Iran.
  • Rezaei MS; Toxoplasmosis Research Center, Communicable Diseases Institute Iranian National Registry Center for Lophomoniasis (INRCL), Mazandaran University of Medical Sciences Sari Iran.
  • Sharifpour A; Radiology Department Iranian National Registry Center for Lophomoniasis (INRCL), Mazandaran University of Medical Sciences Sari Iran.
Respirol Case Rep ; 10(5): e0943, 2022 May.
Article em En | MEDLINE | ID: mdl-35386576
ABSTRACT
A prospective study was conducted from 2017 to 2021 at Bouali Hospital in Mazandaran province, Sari, Iran. Out of 58 patients who were enrolled in our study, lophomoniasis was diagnosed in bronchoalveolar lavage fluid of nine patients, for the first time, using an in-house polymerase chain reaction technique. All patients were treated with metronidazole at 7.5 mg/kg/day every 12 h for 14 days. After 6 months of follow-up, symptoms were fully resolved.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article